Aplastic anemia is divided into acute aplastic anemia and chronic aplastic anemia. Patients with acute aplastic anemia require intensified immunotherapy or allogeneic hematopoietic stem cell transplantation from a sibling match. Intensified immunotherapy involves the simultaneous use of anti-thymocyte globulin (ATG) and cyclosporine. The main treatments for chronic aplastic anemia are immunosuppressive therapy and stimulative hematopoiesis therapy. Immunotherapy primarily involves oral administration of cyclosporine; stimulative hematopoiesis therapy may include oral administration of Chinese patent medicines such as Zao Zeng Xue Pian, and danazol, an anabolic steroid. (Medications should be used under the guidance of a doctor based on the specific circumstances.)